Rock Springs Capital Management as of March 31, 2021
Portfolio Holdings for Rock Springs Capital Management
Rock Springs Capital Management holds 151 positions in its portfolio as reported in the March 2021 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Agios Pharmaceuticals (AGIO) | 2.9 | $131M | 2.5M | 51.64 | |
Humana (HUM) | 2.8 | $126M | 301k | 419.25 | |
Zai Lab Adr (ZLAB) | 2.7 | $125M | 934k | 133.43 | |
Atea Pharmaceuticals (AVIR) | 2.3 | $105M | 1.7M | 61.75 | |
UnitedHealth (UNH) | 2.2 | $102M | 275k | 372.07 | |
Five Prime Therapeutics | 2.2 | $100M | 2.7M | 37.67 | |
Neurocrine Biosciences (NBIX) | 2.2 | $99M | 1.0M | 97.25 | |
Immunocore Hldgs Ads (IMCR) | 2.1 | $98M | 2.3M | 42.57 | |
Insulet Corporation (PODD) | 2.1 | $97M | 371k | 260.92 | |
Align Technology (ALGN) | 2.1 | $96M | 178k | 541.53 | |
Aclaris Therapeutics (ACRS) | 2.0 | $90M | 3.6M | 25.20 | |
Intuitive Surgical Com New (ISRG) | 1.9 | $89M | 120k | 738.94 | |
IDEXX Laboratories (IDXX) | 1.9 | $88M | 180k | 489.31 | |
Hca Holdings (HCA) | 1.8 | $85M | 450k | 188.34 | |
Invitae (NVTAQ) | 1.8 | $85M | 2.2M | 38.21 | |
Novavax Com New (NVAX) | 1.8 | $84M | 461k | 181.31 | |
Argenx Se Sponsored Adr (ARGX) | 1.8 | $83M | 300k | 275.39 | |
Freshpet (FRPT) | 1.8 | $80M | 507k | 158.81 | |
EXACT Sciences Corporation (EXAS) | 1.6 | $75M | 570k | 131.78 | |
Blueprint Medicines (BPMC) | 1.6 | $73M | 747k | 97.23 | |
Pacira Pharmaceuticals (PCRX) | 1.6 | $72M | 1.0M | 70.09 | |
Beigene Sponsored Adr | 1.5 | $70M | 200k | 348.08 | |
Nevro (NVRO) | 1.5 | $68M | 485k | 139.50 | |
Irhythm Technologies (IRTC) | 1.3 | $60M | 433k | 138.86 | |
Horizon Therapeutics Pub L SHS | 1.3 | $58M | 625k | 92.04 | |
Mirati Therapeutics | 1.2 | $55M | 324k | 171.30 | |
Teleflex Incorporated (TFX) | 1.2 | $54M | 130k | 415.46 | |
Bolt Biotherapeutics (BOLT) | 1.1 | $51M | 1.6M | 32.91 | |
Ultragenyx Pharmaceutical (RARE) | 1.1 | $51M | 450k | 113.86 | |
Edwards Lifesciences (EW) | 1.1 | $49M | 582k | 83.64 | |
Mersana Therapeutics (MRSN) | 1.0 | $45M | 2.8M | 16.18 | |
Cullinan Oncology (CGEM) | 1.0 | $45M | 1.1M | 41.67 | |
Karuna Therapeutics Ord | 1.0 | $44M | 369k | 120.23 | |
Phreesia (PHR) | 1.0 | $44M | 850k | 52.10 | |
Eargo | 0.9 | $43M | 852k | 49.95 | |
Alnylam Pharmaceuticals (ALNY) | 0.9 | $42M | 300k | 141.19 | |
Covetrus | 0.9 | $42M | 1.4M | 29.97 | |
Arvinas Ord (ARVN) | 0.9 | $41M | 622k | 66.10 | |
Encompass Health Corp (EHC) | 0.9 | $41M | 500k | 81.90 | |
Acadia Healthcare (ACHC) | 0.9 | $40M | 700k | 57.14 | |
Penumbra (PEN) | 0.9 | $40M | 148k | 270.58 | |
Travere Therapeutics (TVTX) | 0.8 | $37M | 1.5M | 24.97 | |
Health Catalyst (HCAT) | 0.8 | $37M | 785k | 46.77 | |
Allakos (ALLK) | 0.8 | $35M | 306k | 114.78 | |
Seagen | 0.8 | $35M | 250k | 138.86 | |
Ardelyx (ARDX) | 0.7 | $34M | 5.2M | 6.62 | |
Astrazeneca Sponsored Adr (AZN) | 0.7 | $32M | 650k | 49.72 | |
Biogen Idec (BIIB) | 0.7 | $32M | 114k | 279.75 | |
Boston Scientific Corporation (BSX) | 0.7 | $31M | 800k | 38.65 | |
Guardant Health (GH) | 0.7 | $31M | 200k | 152.65 | |
Madrigal Pharmaceuticals (MDGL) | 0.7 | $30M | 259k | 116.97 | |
Ascendis Pharma A/s Sponsored Adr (ASND) | 0.7 | $30M | 234k | 128.88 | |
Mirum Pharmaceuticals (MIRM) | 0.6 | $30M | 1.5M | 19.82 | |
Evolent Health Cl A (EVH) | 0.6 | $29M | 1.4M | 20.20 | |
Prothena Corp SHS (PRTA) | 0.6 | $29M | 1.2M | 25.12 | |
Shockwave Med | 0.6 | $29M | 220k | 130.26 | |
Accolade (ACCD) | 0.6 | $28M | 625k | 45.37 | |
ACADIA Pharmaceuticals (ACAD) | 0.6 | $28M | 1.1M | 25.80 | |
Pulmonx Corp (LUNG) | 0.6 | $27M | 593k | 45.74 | |
Spruce Biosciences (SPRB) | 0.6 | $26M | 1.6M | 16.60 | |
Adaptive Biotechnologies Cor (ADPT) | 0.6 | $26M | 650k | 40.26 | |
Amarin Corp Spons Adr New (AMRN) | 0.6 | $26M | 4.2M | 6.21 | |
Ppd | 0.6 | $26M | 675k | 37.84 | |
Sarepta Therapeutics (SRPT) | 0.5 | $25M | 329k | 74.53 | |
Epizyme | 0.5 | $24M | 2.8M | 8.71 | |
Kymera Therapeutics (KYMR) | 0.5 | $24M | 622k | 38.86 | |
Novocure Ord Shs (NVCR) | 0.5 | $23M | 175k | 132.18 | |
Intersect Ent | 0.5 | $23M | 1.1M | 20.88 | |
Collegium Pharmaceutical Inc Common Stock Usd (COLL) | 0.5 | $22M | 920k | 23.70 | |
Inspire Med Sys (INSP) | 0.5 | $21M | 100k | 206.99 | |
Abcam Ads | 0.4 | $21M | 1.1M | 19.22 | |
Oak Street Health | 0.4 | $20M | 375k | 54.27 | |
Kura Oncology (KURA) | 0.4 | $20M | 710k | 28.27 | |
BioMarin Pharmaceutical (BMRN) | 0.4 | $19M | 254k | 75.51 | |
Cytokinetics Note 4.000%11/1 (Principal) | 0.4 | $19M | 8.0M | 2.39 | |
Rocket Pharmaceuticals (RCKT) | 0.4 | $18M | 403k | 44.37 | |
Sierra Oncology Com New | 0.4 | $18M | 1.0M | 17.23 | |
Gamida Cell SHS | 0.4 | $17M | 2.1M | 8.09 | |
Inozyme Pharma (INZY) | 0.4 | $16M | 828k | 19.80 | |
Prelude Therapeutics (PRLD) | 0.4 | $16M | 378k | 43.33 | |
Dynavax Technologies Corp Com New (DVAX) | 0.4 | $16M | 1.7M | 9.83 | |
Rigel Pharmaceuticals Com New | 0.4 | $16M | 4.7M | 3.42 | |
Nkarta (NKTX) | 0.4 | $16M | 492k | 32.90 | |
Mereo Biopharma Group Ads (MREO) | 0.3 | $15M | 4.5M | 3.37 | |
Akero Therapeutics (AKRO) | 0.3 | $15M | 521k | 29.01 | |
Essa Pharma Com New (EPIX) | 0.3 | $15M | 503k | 29.05 | |
Athira Pharma (ATHA) | 0.3 | $15M | 788k | 18.40 | |
Olink Hldg Ab Sponsored Ads (OLK) | 0.3 | $14M | 400k | 36.00 | |
Spero Therapeutics (SPRO) | 0.3 | $14M | 966k | 14.72 | |
Gossamer Bio Note 5.000% 6/0 (Principal) | 0.3 | $14M | 16M | 0.90 | |
Theravance Biopharma (TBPH) | 0.3 | $14M | 683k | 20.41 | |
Cerevel Therapeutics Hldng I (CERE) | 0.3 | $14M | 1.0M | 13.73 | |
Applied Therapeutics (APLT) | 0.3 | $13M | 702k | 18.75 | |
Tg Therapeutics (TGTX) | 0.3 | $13M | 267k | 48.20 | |
Rhythm Pharmaceuticals (RYTM) | 0.3 | $13M | 599k | 21.27 | |
Galapagos Nv Spon Adr (GLPG) | 0.3 | $13M | 165k | 77.09 | |
Macrogenics (MGNX) | 0.3 | $13M | 394k | 31.85 | |
Aeglea Biotherapeutics | 0.3 | $13M | 1.6M | 7.92 | |
Innovage Hldg Corp (INNV) | 0.3 | $12M | 475k | 25.79 | |
Paratek Pharmaceuticals | 0.3 | $12M | 1.7M | 7.06 | |
Baxter International (BAX) | 0.3 | $12M | 140k | 84.34 | |
Anaptysbio Inc Common (ANAB) | 0.3 | $12M | 535k | 21.55 | |
Shattuck Labs (STTK) | 0.2 | $11M | 389k | 29.24 | |
CONMED Corporation (CNMD) | 0.2 | $11M | 85k | 130.59 | |
Protara Therapeutics Com Stk (TARA) | 0.2 | $11M | 690k | 15.74 | |
Fibrogen (FGEN) | 0.2 | $11M | 313k | 34.71 | |
Translate Bio | 0.2 | $11M | 650k | 16.49 | |
Ngm Biopharmaceuticals | 0.2 | $11M | 365k | 29.07 | |
Prometheus Biosciences | 0.2 | $11M | 575k | 18.26 | |
Compugen Ord (CGEN) | 0.2 | $11M | 1.2M | 8.59 | |
Chinook Therapeutics | 0.2 | $11M | 673k | 15.54 | |
Xenon Pharmaceuticals (XENE) | 0.2 | $10M | 573k | 17.90 | |
Kinnate Biopharma | 0.2 | $10M | 326k | 31.16 | |
Fusion Pharmaceuticals | 0.2 | $10M | 948k | 10.72 | |
Aurinia Pharmaceuticals (AUPH) | 0.2 | $10M | 782k | 12.99 | |
Amicus Therapeutics (FOLD) | 0.2 | $10M | 1.0M | 9.88 | |
Orion Acquisition Corp Unit 02/19/2026 | 0.2 | $10M | 1.0M | 10.00 | |
Design Therapeutics (DSGN) | 0.2 | $9.8M | 327k | 29.90 | |
Nurix Therapeutics (NRIX) | 0.2 | $9.7M | 311k | 31.09 | |
Legend Biotech Corp Sponsored Ads (LEGN) | 0.2 | $9.1M | 313k | 29.02 | |
Relay Therapeutics (RLAY) | 0.2 | $8.7M | 252k | 34.57 | |
Adaptimmune Therapeutics Sponds Adr (ADAP) | 0.2 | $8.2M | 1.5M | 5.31 | |
West Pharmaceutical Services (WST) | 0.2 | $8.0M | 29k | 281.79 | |
Atreca Cl A Com (BCEL) | 0.2 | $7.0M | 454k | 15.33 | |
Chiasma | 0.1 | $6.8M | 2.2M | 3.13 | |
Trillium Therapeutics Com New | 0.1 | $6.7M | 621k | 10.74 | |
Acelrx Pharmaceuticals | 0.1 | $6.4M | 3.8M | 1.70 | |
Fate Therapeutics (FATE) | 0.1 | $5.8M | 70k | 82.46 | |
Constellation Pharmceticls I | 0.1 | $5.4M | 232k | 23.39 | |
Dex (DXCM) | 0.1 | $5.4M | 15k | 359.40 | |
Phasebio Pharmaceuticals | 0.1 | $5.4M | 1.6M | 3.46 | |
Galera Therapeutics (GRTX) | 0.1 | $5.0M | 568k | 8.82 | |
Nuvation Bio Com Cl A (NUVB) | 0.1 | $4.2M | 402k | 10.45 | |
Royalty Pharma Shs Class A (RPRX) | 0.1 | $3.5M | 80k | 43.62 | |
Retrophin Note 2.500% 9/1 (Principal) | 0.1 | $3.4M | 3.3M | 1.03 | |
Bcls Acquisition Corp Com Cl A | 0.1 | $3.3M | 309k | 10.57 | |
Poseida Therapeutics I (PSTX) | 0.1 | $2.8M | 290k | 9.55 | |
Connect Biopharma Hldgs Ads (CNTB) | 0.0 | $2.2M | 119k | 18.50 | |
Lifesci Acquisition Ii Corp | 0.0 | $2.1M | 206k | 10.14 | |
Fs Development Corp Ii Com Cl A | 0.0 | $2.1M | 209k | 9.96 | |
Eucrates Biomedical Acqu Cor Unit 10/23/2027 | 0.0 | $2.1M | 206k | 10.01 | |
Turmeric Acquisition Corp Unit 10/08/2025 | 0.0 | $2.1M | 206k | 10.00 | |
Jiya Acquisition Corp Com Cl A | 0.0 | $2.0M | 206k | 9.84 | |
Population Health Invs Co In Unit 99/99/9999 | 0.0 | $2.0M | 201k | 10.05 | |
Helix Acquisition Corp Com Cl A | 0.0 | $1.6M | 155k | 10.20 | |
Theravance Biopharma Note 3.250%11/0 (Principal) | 0.0 | $1.5M | 1.5M | 1.02 | |
Radius Health Note 3.000% 9/0 (Principal) | 0.0 | $1.4M | 1.5M | 0.93 | |
Neurocrine Biosciences Note 2.250% 5/1 (Principal) | 0.0 | $1.4M | 1.0M | 1.35 | |
Pacira Biosciences Note 2.375% 4/0 (Principal) | 0.0 | $1.2M | 1.0M | 1.21 | |
Nevro Corp Note 2.750% 4/0 (Principal) | 0.0 | $771k | 500k | 1.54 | |
Nuvation Bio *w Exp 07/07/202 (NUVB.WS) | 0.0 | $358k | 134k | 2.67 |